Senior Medical Scientist Liaison (MSL)- South Texas
Gilead Sciences
Summary
As a Senior Medical Science Liaison at Gilead you will be part of the Breast team of Medical Science Liaisons reporting to a regional Field Director. The MSL will disseminate clinical information about Gilead's innovative oncology products to key opinion leaders, academic institutions, community group practices, healthcare professionals (including allied healthcare members), and professional organizations. The geography is South Texas Region.
Job description
Responsibilities
- Responds to clinical inquiries regarding marketed or developmental Gilead products.
- Develops and presents complex scientific and clinical data for these products.
- Identifies and develops regional and national opinion leaders to support Gilead products and trains Gilead approved speakers through personal contacts and on-site visits.
- Establishes strong relationships with opinion leaders, clinical investigators and providers at academic and non-academic settings.
- Provides sales force with training at national and regional levels.
- Works on Gilead Phase IV program that includes collaboration with investigators and internal Gilead personnel.
- Selects sites for both Phase IV and other clinical trials.
- Anticipates complex obstacles and difficulties that may arise in the field and resolves them in a collaborative manner.
- The Senior MSL works collaboratively with Gilead personnel in Sales, Marketing, Clinical Research, Global Safety and Medical Communication.
- Utilizes scientific resources to deliver impactful presentations in a variety of different settings.
- The Senior MSL travels to appointments, meetings and conferences on a frequent and regular basis, occasionally with short notice.
- Must have the ability to work as a member of several teams that may overlap such as national MS team, regional sales team, national accounts, and others.
Requirements
- Advanced degree (i.e. MD, DO, PharmD, PhD, NP/PA) required or may have a BS in pharmacy or BS/MS nursing with varying levels of clinical and/or industry experience.
- Relevant experience must include at least 5 yrs clinical practice experience.
- Clinical practice/industry experience within therapeutic area of interest desirable.
- Demonstrated ability to work independently.
- Well-developed experience in preparing and delivering presentations is required.
- Experience in the management or investigation of clinical trials is required.
- Clinical patient contact experience is required.
- Excellent verbal, written, and interpersonal communication skills are required.
Requirements
- Advanced degree (MD, DO, PharmD, PhD, NP/PA) required or BS in pharmacy or BS/MS nursing with varying levels of clinical and/or industry experience
- At least 5 years clinical practice experience
- Clinical practice/industry experience within therapeutic area of interest desirable
- Demonstrated ability to work independently
- Well-developed experience in preparing and delivering presentations
- Experience in the management or investigation of clinical trials
- Clinical patient contact experience
- Excellent verbal, written, and interpersonal communication skills
Benefits
- Medical, Dental & Vision
- Life Insurance
- Paid Time Off
- Annual Bonus
- Stock-based Long-term Incentives
Company overview
Gilead Sciences, Inc. is a leading American biopharmaceutical company headquartered in Foster City, California, that specializes in researching, developing, and commercializing innovative medicines for life-threatening diseases. Founded in 1987, Gilead has grown into a global healthcare leader with approximately 17,600 employees worldwide. The company's primary therapeutic focus areas include HIV/AIDS, viral hepatitis (hepatitis B and C), oncology, inflammation, and respiratory diseases. Gilead is renowned for its groundbreaking antiviral therapies, including Sovaldi and Harvoni for hepatitis C, and its comprehensive portfolio of HIV treatments such as Truvada, Atripla, and Biktarvy. The company also developed Veklury (remdesivir) for COVID-19 treatment. Gilead operates as a publicly traded company on the NASDAQ (GILD) and is a component of both the Nasdaq-100 and S&P 100 indices. Through strategic acquisitions like Kite Pharma and Immunomedics, Gilead has expanded into cell therapy and oncology, demonstrating its commitment to advancing medical science and improving patient outcomes globally.